| |
 |
 |
 |
Color |
Policy Type |
Countries |
|
Permissive (e.g., SCNT is specifically permitted under certain conditions) |
|
|
Permissive Compromise (e.g., SCNT is prohibited; hESC research using supernumerary IVF embryos is specifically permitted or not prohibited) |
Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland*, France, Georgia, Greece, Hungary, Iceland, Latvia, Moldova, Netherlands, Norway, Portugal, Romania, Russian Federation, San Marino, Slovenia, Switzerland, Turkey |
|
Restrictive Compromise (e.g., hESC research only permitted using cell lines created before a certain date) |
|
|
Prohibitive (e.g., research using embryos or cell products derived from embryos is prohibited) |
|
*Finland is categorized with green and yellow stripes because the relevant law (The Act on Medical Research – No. 488/1999) does not consider the product of SCNT to be an embryo. This law explicitly allows for the use of supernumerary embryos for hESC research and it is understood that SCNT – as it is not prohibited – is permitted in the country.
|
|
|
